CIK 0000021665 · Large accelerated filer
COLGATE PALMOLIVE CO
Sign in to watch- Ticker
- CL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131815595
- Phone
- 2123102000
- Business address
- 300 PARK AVE, NEW YORK, NY, 10022
- Former names
- COLGATE PALMOLIVE CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,027,828
- in 6 filings
Net −$8,027,828. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Tsourapas Panagiotis −$2.9M COO, CD, EMEA, APac, Skin sold 77% of stake
- Hazlin John −$2.3M Chief Growth Officer sold 46% of stake
- Wallace Noel R. −$2.0M Chairman, President & CEO sold 5% of stake
- NORRINGTON LORRIE M −$414K Director sold 9% of stake
- Malcolm Gregory −$402K EVP and Controller sold 29% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-23 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Shares withheld for taxes | −13,081 | $97.10 | $1.3M | 21,629 |
| 2026-02-23 | Wallace Noel R. Chairman, President & CEO | Grant or award | +136,710 | 430,173 | ||
| 2026-02-23 | Wallace Noel R. Chairman, President & CEO | Shares withheld for taxes | −68,252 | $97.10 | $6.6M | 361,921 |
| 2026-02-12 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Option exercise | +15,000 | $76.41 | $1.1M | 25,415 |
| 2026-02-12 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Sale | −15,000 | $97.81 | $1.5M | 10,415 |
| 2026-02-12 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Option exercise · Stock Option (Right to Buy) | −15,000 | 19,938 | ||
| 2026-02-11 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Option exercise | +35,000 | $76.41 | $2.7M | 45,415 |
| 2026-02-11 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Sale | −35,000 | $94.61 | $3.3M | 10,415 |
| 2026-02-11 | Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin | Option exercise · Stock Option (Right to Buy) | −35,000 | 34,938 | ||
| 2026-02-10 | Hazlin John Chief Growth Officer | Option exercise | +20,989 | $76.41 | $1.6M | 38,634 |
| 2026-02-10 | Hazlin John Chief Growth Officer | Sale | −20,989 | $94.25 | $2.0M | 17,645 |
| 2026-02-10 | Hazlin John Chief Growth Officer | Option exercise · Stock Option (Right to Buy) | −20,989 | 0 | ||
| 2026-02-06 | Malcolm Gregory EVP and Controller | Option exercise | +12,747 | $76.41 | $974K | 24,626 |
| 2026-02-06 | Malcolm Gregory EVP and Controller | Sale | −12,747 | $94.91 | $1.2M | 11,879 |
| 2026-02-06 | Malcolm Gregory EVP and Controller | Option exercise · Stock Option (Right to Buy) | −12,747 | 0 | ||
| 2026-02-05 | Massey Sally Chief Human Resources Officer | Option exercise | +15,851 | $76.41 | $1.2M | 29,602 |
| 2026-02-05 | Massey Sally Chief Human Resources Officer | Sale | −15,851 | $95.03 | $1.5M | 13,751 |
| 2026-02-05 | Massey Sally Chief Human Resources Officer | Option exercise · Stock Option (Right to Buy) | −15,851 | 0 | ||
| 2026-02-04 | SUTULA STANLEY J III Chief Financial Officer | Option exercise | +97,843 | $81.78 | $8.0M | 153,153 |
| 2026-02-04 | SUTULA STANLEY J III Chief Financial Officer | Sale | −97,843 | $94.27 | $9.2M | 55,310 |
Page 6 of 10 · 193 trades